Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | 1 | MCP-1 (MCAF) | 306.0 | 50 | |||||||
| RA1869 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 46.0 | 54 | ||||
| RA1869 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 288.5 | 40 | ||||
| N2759 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 117.0 | 45 | ||||
| N2759 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 215.0 | 59 | ||||
| RA1931 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 136.5 | 46 | ||||
| RA1931 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 33.0 | 61 | ||||
| N2586 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 183.0 | 41 | ||||
| N2586 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 124.0 | 41 | ||||
| RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 66.0 | 57 | ||||
| RA1869 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 84.5 | 48 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 85.0 | 62 | ||||
| N2759 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 136.0 | 57 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 108.5 | 68 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 122.5 | 62 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 191.0 | 68 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 90.0 | 51 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 160.0 | 45 | ||||
| RA1869 | 1 | MCP-1 (MCAF) | 455.0 | 42 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 198.5 | 40 | ||||
| N2759 | 1 | MCP-1 (MCAF) | 218.5 | 38 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 243.0 | 36 | ||||
| RA1931 | 1 | MCP-1 (MCAF) | 34.0 | 52 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 405.0 | 45 | ||||
| N2586 | 1 | MCP-1 (MCAF) | 236.5 | 48 |